Insider · CIK 0001875271
Jonathan F Rouis
Files at OBT (Orange County Bancorp, Inc. /DE/). First filing -, latest -.
In brief
Jonathan F Rouis files SEC Form 4 as director at OBT (Orange County Bancorp, Inc. /DE/). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jonathan F Rouis has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 18 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | OBT Orange County Bancorp, Inc. /DE/ | AGrant or award Phantom Stockderivative | - | $37.19 | - | 7,535 | 11 d ago |
| Sep 15, 2026 | OBT Orange County Bancorp, Inc. /DE/ | AGrant or award Phantom Stockderivative | - | $38.78 | - | 7,414 | 27 d ago |
| Jul 1, 2026 | OBT Orange County Bancorp, Inc. /DE/ | AGrant or award Phantom Stockderivative | - | $37.46 | - | 7,380 | Jul 6, 2026 |
| Jun 15, 2026 | OBT Orange County Bancorp, Inc. /DE/ | AGrant or award Phantom Stockderivative | - | $35.35 | - | 7,260 | Jun 17, 2026 |
| Apr 1, 2026 | OBT Orange County Bancorp, Inc. /DE/ | AGrant or award Phantom Stockderivative | - | $32.32 | - | 7,222 | Apr 2, 2026 |
| Mar 16, 2026 | OBT Orange County Bancorp, Inc. /DE/ | AGrant or award Phantom Stockderivative | - | $31.29 | - | 7,083 | Mar 17, 2026 |
| Feb 19, 2026 | OBT Orange County Bancorp, Inc. /DE/ | AGrant or award Common Stock | +866 | $0.00 | $0 | 10,161 | Feb 23, 2026 |
| Feb 20, 2026 | OBT Orange County Bancorp, Inc. /DE/ | DDisposition to issuer Common Stock | -995 | - | - | 9,166 | Feb 23, 2026 |
| Feb 20, 2026 | OBT Orange County Bancorp, Inc. /DE/ | AGrant or award Phantom Stockderivative | - | - | - | 7,043 | Feb 23, 2026 |
| Jan 2, 2026 | OBT Orange County Bancorp, Inc. /DE/ | AGrant or award Phantom Stockderivative | +159 | $28.35 | $4,508 | 6,032 | Jan 5, 2026 |
| Dec 16, 2025 | OBT Orange County Bancorp, Inc. /DE/ | AGrant or award Phantom Stockderivative | +36 | $28.95 | $1,042 | 5,873 | Dec 17, 2025 |
| Oct 1, 2025 | OBT Orange County Bancorp, Inc. /DE/ | AGrant or award Phantom Stockderivative | - | $25.10 | - | 5,837 | Oct 2, 2025 |
| Sep 16, 2025 | OBT Orange County Bancorp, Inc. /DE/ | AGrant or award Phantom Stockderivative | - | $25.95 | - | 5,658 | Sep 17, 2025 |
| Jul 1, 2025 | OBT Orange County Bancorp, Inc. /DE/ | AGrant or award Phantom Stockderivative | +170 | $26.49 | $4,503 | 5,630 | Jul 2, 2025 |
| Jun 16, 2025 | OBT Orange County Bancorp, Inc. /DE/ | AGrant or award Stock Optionsderivative | +31 | $23.14 | $717 | 5,460 | Jun 18, 2025 |
| Apr 1, 2025 | OBT Orange County Bancorp, Inc. /DE/ | AGrant or award Phantom Stockderivative | - | $23.91 | - | 5,429 | Apr 3, 2025 |
| Dec 16, 2024 | OBT Orange County Bancorp, Inc. /DE/ | AGrant or award Phantom Stockderivative | - | $59.24 | - | 1,503 | Dec 18, 2024 |
| Dec 15, 2023 | OBT Orange County Bancorp, Inc. /DE/ | AGrant or award Phantom Stockderivative | - | $58.00 | - | 1,192 | Dec 18, 2023 |
Questions about Jonathan F Rouis
Answered from the filings on this page, as of the latest one.
Is Jonathan F Rouis buying or selling?
Jonathan F Rouis has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jonathan F Rouis's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jonathan F Rouis has 0.
Where does Jonathan F Rouis file Form 4?
Jonathan F Rouis has filed Form 4 at OBT (Orange County Bancorp, Inc. /DE/). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.